Title:
細胞含有製剤
Document Type and Number:
Japanese Patent JP4563937
Kind Code:
B2
Abstract:
The present invention provides a cell-containing preparation comprising cells containing a DNA having a base sequence represented by SEQ ID NO:1 or 2, or a DNA hybridizable with a DNA having a base sequence represented by SEQ ID NO:1 or 2 under stringent conditions, and a fibrous protein. The cell-containing preparation of the present invention makes it possible to more efficiently supply NK4 having an inhibitory action against the growth or metastasis of cancers to cancer cells.
Inventors:
Toshikazu Nakamura
Takehisa Matsuda
Masao Tanaka
Tatsuya Manabe
Kunio Matsumoto
Takehisa Matsuda
Masao Tanaka
Tatsuya Manabe
Kunio Matsumoto
Application Number:
JP2005506721A
Publication Date:
October 20, 2010
Filing Date:
January 23, 2004
Export Citation:
Assignee:
Toshikazu Nakamura
Kringle Pharma Co., Ltd.
Kringle Pharma Co., Ltd.
International Classes:
A61K35/36; A61K35/12; A61K35/33; A61K35/38; A61K38/00; A61K38/18; A61K47/34; A61K47/42; A61L27/00; A61L27/22; A61L27/24; A61L27/38; A61L27/54; A61L27/58; A61P35/00; A61P43/00
Foreign References:
| WO1992009702A1 | 1992-06-11 | |||
| WO2000061156A2 | 2000-10-19 |
Attorney, Agent or Firm:
Ryu Iwatani